TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER

CEFOXITIN SODIUM
Immunology Approved 2006-03-10
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
20
Years on Market

Details

Status
Prescription
First Approved
2006-03-10
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

B BRAUN
Active Ingredient: CEFOXITIN SODIUM

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER Approval History

Loading approval history...

What CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER Treats

10 indications

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER is approved for 10 conditions since its original approval in 2006. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Lower Respiratory Tract Infection
  • Pneumonia
  • Lung Abscess
  • Urinary Tract Infection
  • Intra-Abdominal Infection
  • Peritonitis
  • Intra-Abdominal Abscess
  • Gynecological Infection
Source: FDA Label

Drugs Similar to CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CEFOXITIN IN PLASTIC CONTAINER
CEFOXITIN SODIUM
10 shared
SAMSON MEDCL
Shared indications:
Lower Respiratory Tract InfectionPneumoniaLung Abscess +7 more
CLEOCIN HYDROCHLORIDE
CLINDAMYCIN HYDROCHLORIDE
6 shared
Pfizer
Shared indications:
Intra-abdominal InfectionPeritonitisIntra-abdominal Abscess +3 more
CLINDAMYCIN HYDROCHLORIDE
CLINDAMYCIN HYDROCHLORIDE
5 shared
GLENMARK PHARMS LTD
Shared indications:
Intra-Abdominal InfectionPeritonitisIntra-Abdominal Abscess +2 more
CLINDAMYCIN PALMITATE HYDROCHLORIDE
CLINDAMYCIN PALMITATE HYDROCHLORIDE
5 shared
RISING
Shared indications:
Lung AbscessIntra-Abdominal InfectionPeritonitis +2 more
ARIKAYCE KIT
AMIKACIN SULFATE
3 shared
INSMED INC
Shared indications:
Intra-Abdominal InfectionPeritonitisUrinary Tract Infection
AZACTAM
AZTREONAM
3 shared
Bristol-Myers Squibb
Shared indications:
Urinary Tract InfectionLower Respiratory Tract InfectionPneumonia
AZTREONAM
AZTREONAM
3 shared
Pfizer
Shared indications:
Urinary Tract InfectionLower Respiratory Tract InfectionPneumonia
CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE
3 shared
QILU ANTIBIOTICS
Shared indications:
PneumoniaUrinary Tract InfectionIntra-Abdominal Infection
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
3 shared
SAMSON MEDCL
Shared indications:
PneumoniaUrinary Tract InfectionIntra-Abdominal Infection
CEFEPIME IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
3 shared
Baxter
Shared indications:
PneumoniaUrinary Tract InfectionIntra-Abdominal Infection
CEFUROXIME
CEFUROXIME
3 shared
Hikma
Shared indications:
Lower Respiratory Tract InfectionPneumoniaUrinary Tract Infection
DIFLUCAN
FLUCONAZOLE
3 shared
Pfizer
Shared indications:
Urinary Tract InfectionPeritonitisPneumonia
TAZICEF
CEFTAZIDIME
3 shared
Pfizer
Shared indications:
Lower Respiratory Tract InfectionPneumoniaUrinary Tract Infection
AMOXICILLIN PEDIATRIC
AMOXICILLIN
2 shared
Teva
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
AUGMENTIN '125'
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
AUGMENTIN '250'
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
AUGMENTIN '875'
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
AUGMENTIN XR
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
CASPOFUNGIN ACETATE
CASPOFUNGIN ACETATE
2 shared
HENGRUI PHARMA
Shared indications:
Intra-abdominal AbscessPeritonitis
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
CEFEPIME HYDROCHLORIDE
2 shared
B BRAUN
Shared indications:
PneumoniaUrinary Tract Infection
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

: Treatment: CEFOXITIN FOR INJECTION, USP is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. Lower respiratory tract infections , including pneumonia and lung abscess, caused by Streptococcus pneumoniae , other streptococci (excluding enterococci, e.g., Enterococcus faecalis [formerly Streptococcus faecalis ]), Staphylococcus aureus (including penicillinase-producing strains), Escherichia coli, Klebsiella species, Haemophilus influenzae, and Bacteroides species. Urinary tract infections caused by Esc...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA065214 → Label: DailyMed → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.